Security Snapshot

Dermata Therapeutics, Inc. - Common Stock, $0.0001 par value (DRMA) Institutional Ownership

CUSIP: 249845108

13F Institutional Holders and Ownership History from Q3 2021 to Q1 2023

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
4,021,390
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • DRMA - Dermata Therapeutics, Inc. - Common Stock, $0.0001 par value is tracked under CUSIP 249845108.
  • Latest finished 13F holder period is not available.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 11 to 0 between Q4 2022 and Q1 2023.
  • SEC-reported value moved from $118,779 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

249845108

Latest holder period

n/a

13F holders

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
DRMA
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PROEHL GERALD T 7.8% -48% 804,098 +0.04% PROEHL GERALD T 27 Mar 2025
BIGGER CAPITAL FUND L P 1.9% 75,200 BIGGER CAPITAL FUND L P 31 Mar 2026

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
7
Latest
n/a
Rows shown
1-7 of 7
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q1 0 $0 -$118,779 0
2022 Q4 292,762 $118,779 +$27,793 $0.41 11
2022 Q3 197,202 $101,000 -$441,932 $0.50 9
2022 Q2 853,426 $554,000 +$495,899 $0.64 10
2022 Q1 72,671 $91,000 -$112,276 $1.27 7
2021 Q4 130,204 $226,000 -$886,851 $1.75 10
2021 Q3 263,947 $1,186,000 +$1,186,000 $4.49 7
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .